Cytokine Profiles at Birth Predict Malaria Severity during Infancy

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Kabyemela, Edward ^a,f   Gonçalves, Bronner P ^b   Prevots, D Rebecca ^b   Morrison, Robert ^a,f   Harrington, Whitney ^c   Gwamaka, Moses ^a,f   Kurtis, Jonathan D ^d,e   Fried, Michal ^a,b,f   Duffy, Patrick E ^a,b,f  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e BROWN UNIVERSITY   (United States)

^f Muheza Designated District Hospital   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SMEAR; CHILD; CLINICAL ASSESSMENT; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFANCY; INFANT; INFECTION CONTROL; INFECTION RISK; INFLAMMATION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NEWBORN; PARASITE LOAD; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RISK REDUCTION; TANZANIA;

CHILD, PRESCHOOL; COHORT STUDIES; CYTOKINES; FEMALE; FETAL BLOOD; HUMANS; INFANT; MALARIA; MALE; PARTURITION; PLASMODIUM; RISK; SEVERITY OF ILLNESS INDEX; TANZANIA;

EID: 84885415933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077214     Document Type: Article

References (43)

1. (2012) World Malaria Report. Geneva: World Health Organization.
2. Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, et al. (2005) Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 192: 178-186. doi:10.1086/430744. PubMed: 15942909.
3. Mackinnon MJ, Mwangi TW, Snow RW, Marsh K, Williams TN, (2005) Heritability of malaria in Africa. PLOS Med 2: e340. doi:10.1371/journal.pmed.0020340. PubMed: 16259530.
4. Fortin A, Stevenson MM, Gros P, (2002) Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Hum Mol Genet 11: 2469-2478. doi:10.1093/hmg/11.20.2469. PubMed: 12351583.
5. Gupta S, Hill AV, Kwiatkowski D, Greenwood AM, Greenwood BM, et al. (1994) Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A 91: 3715-3719. doi:10.1073/pnas.91.9.3715. PubMed: 8170975.
6. Al-Taiar A, Assabri A, Al-Habori M, Azazy A, Algabri A, et al. (2009) Socioeconomic and environmental factors important for acquiring non-severe malaria in children in Yemen: a case-control study. Trans R Soc Trop Med Hyg 103: 72-78. doi:10.1016/j.trstmh.2008.09.010. PubMed: 18950826.
7. Doolan DL, Dobaño C, Baird JK, (2009) Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36. doi:10.1128/CMR.00025-08. PubMed: 19136431.
8. Angulo I, Fresno M, (2002) Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol 9: 1145-1152. PubMed: 12414742.
9. Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, et al. (2002) Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis 185: 971-979. doi:10.1086/339408. PubMed: 11920322.
10. Rockett KA, Awburn MM, Aggarwal BB, Cowden WB, Clark IA, (1992) In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun 60: 3725-3730. PubMed: 1500182.
11. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P, (1995) Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182: 409-418. doi:10.1084/jem.182.2.409. PubMed: 7629503.
12. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, et al. (1989) Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320: 1586-1591. doi:10.1056/NEJM198906153202404. PubMed: 2657427.
13. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204. doi:10.1016/0140-6736(90)92827-5. PubMed: 1978068.
14. Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, et al. (1998) Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772. doi:10.1016/S0140-6736(97)09439-7. PubMed: 9635949.
15. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, et al. (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 179: 279-282. doi:10.1086/314548. PubMed: 9841855.
16. Hugosson E, Montgomery SM, Premji Z, Troye-Blomberg M, Björkman A, (2004) Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparum parasites. Parasite Immunol 26: 111-117. doi:10.1111/j.0141-9838.2004.00678.x. PubMed: 15279621.
17. Fievet N, Ringwald P, Bickii J, Dubois B, Maubert B, et al. (1996) Malaria cellular immune responses in neonates from Cameroon. Parasite Immunol 18: 483-490. doi:10.1046/j.1365-3024.1996.d01-19.x. PubMed: 9226685.
18. King CL, Malhotra I, Wamachi A, Kioko J, Mungai P, et al. (2002) Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol 168: 356-364. PubMed: 11751981.
19. Malhotra I, Mungai P, Muchiri E, Ouma J, Sharma S, et al. (2005) Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 73: 3462-3470. doi:10.1128/IAI.73.6.3462-3470.2005. PubMed: 15908375.
20. Malhotra I, Dent A, Mungai P, Wamachi A, Ouma JH, et al. (2009) Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLOS Med 6: e1000116.
21. Mutabingwa TK, Bolla MC, Li JL, Domingo GJ, Li X, et al. (2005) Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLOS Med 2: e407. doi:10.1371/journal.pmed.0020407. PubMed: 16259531.
22. (2000) Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1):: S1-90. doi:10.1016/S0035-9203(00)90413-9. PubMed: 11103309.
23. Chong SS, Boehm CD, Higgs DR, Cutting GR, (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95: 360-362. PubMed: 10607725.
24. Coutinho HM, McGarvey ST, Acosta LP, Manalo DL, Langdon GC, et al. (2005) Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 192: 528-536.
25. Schwarz NG, Adegnika AA, Breitling LP, Gabor J, Agnandji ST, et al. (2008) Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis 47: 1017-1025. doi:10.1086/591968. PubMed: 18781874.
26. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE, (2008) Fetal responses during placental malaria modify the risk of low birth weight. Infect Immun 76: 1527-1534. doi:10.1128/IAI.00964-07. PubMed: 18212078.
27. Kabyemela ER, Muehlenbachs A, Fried M, Kurtis JD, Mutabingwa TK, et al. (2008) Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria. Malar J 7: 26. doi:10.1186/1475-2875-7-26. PubMed: 18230163.
28. Wenisch C, Parschalk B, Narzt E, Looareesuwan S, Graninger W, (1995) Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 74: 115-117. doi:10.1006/clin.1995.1017. PubMed: 7994921.
29. Hensmann M, Kwiatkowski D, (2001) Cellular basis of early cytokine response to Plasmodium falciparum. Infect Immun 69: 2364-2371. doi:10.1128/IAI.69.4.2364-2371.2001. PubMed: 11254594.
30. Ly NP, Rifas-Shiman SL, Litonjua AA, Tzianabos AO, Schaub B, et al. (2007) Cord blood cytokines and acute lower respiratory illnesses in the first year of life. Pediatrics 119: e171-e178. doi:10.1542/peds.2006-3134. PubMed: 17145902.
31. Jacobs P, Radzioch D, Stevenson MM, (1996) In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect Immun 64: 44-49. PubMed: 8557372.
32. Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, et al. (1995) Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg 53: 532-538. PubMed: 7485713.
33. Mordmüller BG, Metzger WG, Juillard P, Brinkman BM, Verweij CL, et al. (1997) Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw 8: 29-35. PubMed: 9110145.
34. Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, et al. (2009) Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 77: 3033-3043. doi:10.1128/IAI.00211-09. PubMed: 19380468.
35. Ramharter M, Kremsner PG, Willheim M, Winkler H, Graninger W, et al. (2004) Plasmodium falciparum-specific interleukin-2 and tumor necrosis factor-alpha expressing-T cells are associated with resistance to reinfection and severe malaria in healthy African children. Eur Cytokine Netw 15: 189-196. PubMed: 15542442.
36. Rockett KA, Awburn MM, Rockett EJ, Clark IA, (1994) Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am J Trop Med Hyg 50: 735-742. PubMed: 8024067.
37. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, et al. (1999) Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis 179: 980-988. doi:10.1086/314689. PubMed: 10068595.
38. Rockett KA, Awburn MM, Cowden WB, Clark IA, (1991) Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 59: 3280-3283. PubMed: 1879941.
39. Pied S, Civas A, Berlot-Picard F, Renia L, Miltgen F, et al. (1992) IL-6 induced by IL-1 inhibits malaria pre-erythrocytic stages but its secretion is down-regulated by the parasite. J Immunol 148: 197-201. PubMed: 1727866.
40. Curfs JH, van der Meer JW, Sauerwein RW, Eling WM, (1990) Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med 172: 1287-1291. doi:10.1084/jem.172.5.1287. PubMed: 2230643.
41. Ouma C, Davenport GC, Awandare GA, Keller CC, Were T, et al. (2008) Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. J Infect Dis 198: 1219-1226. doi:10.1086/592055. PubMed: 18781863.
42. Le Hesran JY, Cot M, Personne P, Fievet N, Dubois B, et al. (1997) Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol 146: 826-831. doi:10.1093/oxfordjournals.aje.a009200. PubMed: 9384203.
43. Thuma PE, van Dijk J, Bucala R, Debebe Z, Nekhai S, et al. (2011) Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia. J Infect Dis 203: 211-219. doi:10.1093/infdis/jiq041. PubMed: 21288821.